Literature DB >> 31792602

The CALIPER-Revised Version of the Composite Physiologic Index is a Better Predictor of Survival in IPF than the Original Version.

Karishma S Hosein1, Gianluigi Sergiacomi2, Maurizio Zompatori3, Marco Mura4.   

Abstract

CALIPER is a computer-based quantitative algorithm to accurately characterize and quantify pulmonary fibrosis, and a revised version of composite physiologic index (CPI) has been developed against this new algorithm. The prognostic capabilities of the original and CALIPER-revised versions of CPI were compared in a cohort of 185 patients with IPF prospectively followed in 2 centers. CALIPER-revised CPI was a significant risk factor towards lung transplant (LTx)-free survival, with enhanced hazard ratio (5.68) compared to the original CPI (5.36). Accuracy of LTx-free survival was substantially improved with CALIPER-revised CPI (area under the curve [AUC] 0.75 vs. 0.66), with much better specificity (83% vs. 55%). Six-month changes of CALIPER-revised CPI predicted survival significantly (AUC 0.65). CALIPER-revised CPI is a better predictor of LTx-free survival in patients with IPF. Since CALIPER technology is not available to all centers, this simple and easy to obtain tool may be used to guide management decisions in IPF.

Entities:  

Keywords:  CALIPER; CPI; Idiopathic pulmonary fibrosis; Prognosis; Survival

Mesh:

Year:  2019        PMID: 31792602     DOI: 10.1007/s00408-019-00295-4

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  15 in total

1.  Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures.

Authors:  Joseph Jacob; Brian J Bartholmai; Srinivasan Rajagopalan; Maria Kokosi; Arjun Nair; Ronald Karwoski; Simon L F Walsh; Athol U Wells; David M Hansell
Journal:  Eur Respir J       Date:  2017-01-25       Impact factor: 16.671

2.  Multi-dimensional scores to predict mortality in patients with idiopathic pulmonary fibrosis undergoing lung transplantation assessment.

Authors:  Jolene H Fisher; Faris Al-Hejaili; Sonja Kandel; Alim Hirji; Shane Shapera; Marco Mura
Journal:  Respir Med       Date:  2017-03-06       Impact factor: 3.415

3.  Idiopathic Pulmonary Fibrosis: Gender-Age-Physiology Index Stage for Predicting Future Lung Function Decline.

Authors:  Margaret L Salisbury; Meng Xia; Yueren Zhou; Susan Murray; Nabihah Tayob; Kevin K Brown; Athol U Wells; Shelley L Schmidt; Fernando J Martinez; Kevin R Flaherty
Journal:  Chest       Date:  2016-01-12       Impact factor: 9.410

4.  Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity.

Authors:  Hana Serajeddini; Paola Rogliani; Marco Mura
Journal:  Lung       Date:  2018-08-27       Impact factor: 2.584

5.  Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography.

Authors:  Athol U Wells; Sujal R Desai; Michael B Rubens; Nicole S L Goh; Derek Cramer; Andrew G Nicholson; Thomas V Colby; Roland M du Bois; David M Hansell
Journal:  Am J Respir Crit Care Med       Date:  2003-04-01       Impact factor: 21.405

6.  Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema.

Authors:  S L Schmidt; A M Nambiar; N Tayob; B Sundaram; M K Han; B H Gross; E A Kazerooni; A R Chughtai; A Lagstein; J L Myers; S Murray; G B Toews; F J Martinez; K R Flaherty
Journal:  Eur Respir J       Date:  2010-12-09       Impact factor: 16.671

7.  Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?

Authors:  Kevin R Flaherty; Talmadge E King; Ganesh Raghu; Joseph P Lynch; Thomas V Colby; William D Travis; Barry H Gross; Ella A Kazerooni; Galen B Toews; Qi Long; Susan Murray; Vibha N Lama; Steven E Gay; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2004-07-15       Impact factor: 21.405

8.  Automated Quantitative Computed Tomography Versus Visual Computed Tomography Scoring in Idiopathic Pulmonary Fibrosis: Validation Against Pulmonary Function.

Authors:  Joseph Jacob; Brian J Bartholmai; Srinivasan Rajagopalan; Maria Kokosi; Arjun Nair; Ronald Karwoski; Sushravya M Raghunath; Simon L F Walsh; Athol U Wells; David M Hansell
Journal:  J Thorac Imaging       Date:  2016-09       Impact factor: 3.000

9.  A multidimensional index and staging system for idiopathic pulmonary fibrosis.

Authors:  Brett Ley; Christopher J Ryerson; Eric Vittinghoff; Jay H Ryu; Sara Tomassetti; Joyce S Lee; Venerino Poletti; Matteo Buccioli; Brett M Elicker; Kirk D Jones; Talmadge E King; Harold R Collard
Journal:  Ann Intern Med       Date:  2012-05-15       Impact factor: 25.391

10.  Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Jeffrey L Myers; Luca Richeldi; Christopher J Ryerson; David J Lederer; Juergen Behr; Vincent Cottin; Sonye K Danoff; Ferran Morell; Kevin R Flaherty; Athol Wells; Fernando J Martinez; Arata Azuma; Thomas J Bice; Demosthenes Bouros; Kevin K Brown; Harold R Collard; Abhijit Duggal; Liam Galvin; Yoshikazu Inoue; R Gisli Jenkins; Takeshi Johkoh; Ella A Kazerooni; Masanori Kitaichi; Shandra L Knight; George Mansour; Andrew G Nicholson; Sudhakar N J Pipavath; Ivette Buendía-Roldán; Moisés Selman; William D Travis; Simon Walsh; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2018-09-01       Impact factor: 21.405

View more
  2 in total

1.  LUNG Year in Review: 2020.

Authors:  Peter V Dicpinigaitis
Journal:  Lung       Date:  2021-01-26       Impact factor: 2.584

2.  Validation of the risk stratification score in idiopathic pulmonary fibrosis: study protocol of a prospective, multi-centre, observational, 3-year clinical trial.

Authors:  Gian Marco Manzetti; Karishma Hosein; Matthew J Cecchini; Keith Kwan; Mohamed Abdelrazek; Maurizio Zompatori; Paola Rogliani; Marco Mura
Journal:  BMC Pulm Med       Date:  2021-12-04       Impact factor: 3.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.